AI just engineered 16 functional viral genomes from scratch, built to kill drug-resistant bacteria. Crafted by researchers at Stanford and the Arc Institute, the genomes are engineered to target E.coli, including strains that have always been resistant to the natural phage. The faster AI crafts biological design, the more manufacturing and clinical validation become the real bottleneck to patient delivery. More on Lightwork: → As foundation models get more capable and established players build out their own AI stacks, the moat for healthcare startups increasingly appears to sit in distribution and trust. → Healthcare, initially a slower adopter of AI, is having a leapfrog moment. Some physicians are embracing tools like scribing and voice AI, setting a new tone for healthcare adoption. Full video below. CC: Claire Zau, Brenton Fargnoli, M.D.
Everyone was talking about AI-designed viruses last week, so we brought on a real doctor investor to unpack what's actually happening. Dr. Brenton Fargnoli, M.D. breaks down the research + we discuss the new moats for building vertical AI in healthcare, and where founders could be looking to build. 1:11 Did AI design 16 new viruses? 5:54 Could AI-Designed Viruses Infect Humans? 6:32 AI, Antibiotic Resistance & Medical Applications 10:47 Building Vertical AI in Healthcare 13:39 What's Making Healthcare AI Ripe for Startups? 16:19 How Founders Can Compete With Big Tech 20:13 What Makes a Great Healthcare AI Founder? 23:06 Predictions for Epic's UGM 2026 FULL EPISODE BELOW Lightspeed